Katharine M. Dermigny is a Pittsburgh, Pennsylvania based neurologist who is specialized in Neurology. Active license number of Katharine M. Dermigny is 330465 for Neurology in New York. Her current practice location is 3471 5th Ave Ste 811, Pittsburgh. Patients can reach her at 412-692-4920. Katharine M. Dermigny NPI number (Unique professional ID assigned by NPPES) is 1558927525. Katharine M. Dermigny specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Katharine M. Dermigny speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1558927525
NPI Enumeration Date:
15 May, 2019
NPI Last Update On:
20 Jun, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Katharine M. Dermigny are as mentioned below.
License Number
Specialization
State
Status
330465
Neurology
New York
Primary
Student in an Organized Health Care Education/Training Program
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Katharine M. Dermigny 3600 Forbes Ave, Forbes Tower - Plaze Level Suite 140 Pittsburgh, Pennsylvania
Zip:
15213
Patients can reach Katharine M. Dermigny at 3471 5th Ave Ste 811, Pittsburgh, Pennsylvania or can call to book an appointment on 412-692-4920.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.